[HTML][HTML] Update on heart failure management and future directions
HM Choi, MS Park, JC Youn - The Korean journal of internal …, 2019 - ncbi.nlm.nih.gov
Heart failure (HF) is an important cardiovascular disease because of its increasing
prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The …
prevalence, significant morbidity, high mortality, and rapidly expanding health care cost. The …
Novel oxidative stress biomarkers with risk prognosis values in heart failure
Oxidative stress (OS) is mediated by reactive oxygen species (ROS), which in
cardiovascular and other disease states, damage DNA, lipids, proteins, other cellular and …
cardiovascular and other disease states, damage DNA, lipids, proteins, other cellular and …
[HTML][HTML] Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics
JR Bhagwan, D Mosqueira, K Chairez-Cantu… - Journal of molecular and …, 2020 - Elsevier
Background Hypertrophic cardiomyopathy (HCM) is a prevalent and complex cardiovascular
condition. Despite being strongly associated with genetic alterations, wide variation of …
condition. Despite being strongly associated with genetic alterations, wide variation of …
Novel therapies for prevention and early treatment of cardiomyopathies: now and in the future
GG Repetti, CN Toepfer, JG Seidman… - Circulation …, 2019 - Am Heart Assoc
Heritable cardiomyopathies are a class of heart diseases caused by variations in a number
of genetic loci. Genetic variants on one allele lead to either a degraded protein, which …
of genetic loci. Genetic variants on one allele lead to either a degraded protein, which …
Heart failure with preserved ejection fraction: The pathophysiological mechanisms behind the clinical phenotypes and the therapeutic approach
L Stoicescu, D Crişan, C Morgovan, L Avram… - International Journal of …, 2024 - mdpi.com
Heart failure (HF) with preserved ejection fraction (HFpEF) is an increasingly frequent form
and is estimated to be the dominant form of HF. On the other hand, HFpEF is a syndrome …
and is estimated to be the dominant form of HF. On the other hand, HFpEF is a syndrome …
The future of heart failure with preserved ejection fraction: Deep phenotyping for targeted therapeutics
FR Heinzel, SJ Shah - Herz, 2022 - Springer
Heart failure (HF) with preserved ejection fraction (HFpEF) is a multi-organ, systemic
syndrome that involves multiple cardiac and extracardiac pathophysiologic abnormalities …
syndrome that involves multiple cardiac and extracardiac pathophysiologic abnormalities …
[HTML][HTML] Modeling hypertrophic cardiomyopathy: mechanistic insights and pharmacological intervention
D Mosqueira, JGW Smith, JR Bhagwan… - Trends in molecular …, 2019 - cell.com
Hypertrophic cardiomyopathy (HCM) is a prevalent and complex cardiovascular disease
where cardiac dysfunction often associates with mutations in sarcomeric genes. Various …
where cardiac dysfunction often associates with mutations in sarcomeric genes. Various …
Myocardial contractility: historical and contemporary considerations
WW Muir, RL Hamlin - Frontiers in Physiology, 2020 - frontiersin.org
The term myocardial contractility is thought to have originated more than 125 years ago and
has remained and enigma ever since. Although the term is frequently used in textbooks …
has remained and enigma ever since. Although the term is frequently used in textbooks …
[HTML][HTML] Omecamtiv mecarbil: a novel mechanistic and therapeutic approach to chronic heart failure management
Heart failure (HF) is a major public health problem in the United States as well as worldwide.
Chronic heart failure is a syndrome of reduced cardiac output resulting from impaired …
Chronic heart failure is a syndrome of reduced cardiac output resulting from impaired …
New targets in heart failure drug therapy
M Correale, L Tricarico, M Fortunato… - Frontiers in …, 2021 - frontiersin.org
Despite recent advances in chronic heart failure management (either pharmacological or
non-pharmacological), the prognosis of heart failure (HF) patients remains poor. This poor …
non-pharmacological), the prognosis of heart failure (HF) patients remains poor. This poor …